Huntington National Bank Buys 7,408 Shares of Corteva, Inc. (NYSE:CTVA)

Huntington National Bank raised its stake in shares of Corteva, Inc. (NYSE:CTVA) by 2.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 342,340 shares of the company’s stock after purchasing an additional 7,408 shares during the period. Huntington National Bank’s holdings in Corteva were worth $19,500,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Oak Thistle LLC purchased a new position in shares of Corteva during the 4th quarter valued at $1,514,000. Van ECK Associates Corp lifted its position in shares of Corteva by 5.9% in the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company’s stock valued at $537,031,000 after acquiring an additional 525,531 shares in the last quarter. Swedbank AB boosted its stake in shares of Corteva by 51.9% in the fourth quarter. Swedbank AB now owns 695,641 shares of the company’s stock worth $39,624,000 after acquiring an additional 237,764 shares during the period. Assenagon Asset Management S.A. grew its position in shares of Corteva by 755.8% during the fourth quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company’s stock worth $31,486,000 after purchasing an additional 488,181 shares in the last quarter. Finally, S.E.E.D. Planning Group LLC raised its stake in Corteva by 54.5% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 96,103 shares of the company’s stock valued at $5,474,000 after purchasing an additional 33,886 shares during the period. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the firm’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares in the company, valued at $723,257.78. This trade represents a 70.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.14% of the stock is currently owned by company insiders.

Corteva Stock Performance

Shares of NYSE:CTVA opened at $63.54 on Wednesday. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 12 month low of $50.01 and a 12 month high of $66.24. The company has a market capitalization of $43.40 billion, a price-to-earnings ratio of 49.26, a PEG ratio of 1.68 and a beta of 0.79. The firm’s 50-day moving average is $62.56 and its 200 day moving average is $60.23.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. Research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s dividend payout ratio is presently 52.71%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on CTVA shares. The Goldman Sachs Group started coverage on shares of Corteva in a report on Thursday, March 13th. They set a “buy” rating and a $71.00 price objective for the company. BNP Paribas upgraded shares of Corteva to a “hold” rating in a report on Monday, February 10th. UBS Group dropped their price objective on shares of Corteva from $74.00 to $73.00 and set a “buy” rating for the company in a report on Friday, January 10th. Citigroup lifted their target price on Corteva from $69.00 to $74.00 and gave the stock a “buy” rating in a report on Wednesday, January 29th. Finally, Argus raised Corteva from a “hold” rating to a “buy” rating and set a $69.00 price target for the company in a research note on Monday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $68.06.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.